Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02535442 · ClinicalTrials.gov registry record
Nasal Swab Study to Explore the Nasal Microbia
A clinical trial, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- 42
- Enrollment target
NCT02535442 is a clinical trial that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 42 participants.
The verdict
NCT02535442 has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02535442
The ClinicalTrials.gov registry entry for NCT02535442 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly-Clark Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02535442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02535442 about?
NCT02535442 is a clinical study titled "Nasal Swab Study to Explore the Nasal Microbia". The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.
What is the current status of trial NCT02535442?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2015-08. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02535442?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.